Infection and Immunity, July 2001, p. 4661-4666, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4661-4666.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Center, Calgary, Alberta, Canada T2N 4N1,1 and Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada T6G 2E92
Received 22 January 2001/Returned for modification 22 February 2001/Accepted 26 March 2001
| |
ABSTRACT |
|---|
|
|
|---|
The distribution of quorum-sensing genes among strains from seven genomovars of the Burkholderia cepacia complex was examined by PCR. cepR and cepI were amplified from B. cepacia genomovars I and III, B. stabilis, and B. vietnamiensis. cepR was also amplified from B. multivorans and B. cepacia genomovar VI. bviIR were amplified from B. vietnamiensis. All genomovars produced N-octanoyl-L-homoserine lactone and N-hexanoyl-L-homoserine lactone. B. vietnamiensis and B. cepacia genomovar VII produced additional N-acyl-L-homoserine lactones.
| |
TEXT |
|---|
|
|
|---|
Burkholderia cepacia is an opportunistic pathogen that infects patients with cystic fibrosis (CF) (10, 12, 13). Some patients infected with B. cepacia develop cepacia syndrome, a necrotizing, often fatal pneumonia sometimes associated with bacteremia (14). Colonization with B. cepacia correlates with an increased risk of mortality at all levels of pulmonary function (4). The transmissibility of B. cepacia between CF patients (11, 15, 20, 26) and intrinsic resistance to a wide variety of antibiotics (25) are of increasing concern in the CF community.
B. cepacia was originally classified in the genus Pseudomonas but was transferred to the genus Burkholderia in 1992 on the basis of rRNA sequence analysis (35). Recently, B. cepacia has been classified into genotypically distinct species or genomovars referred to as the "B. cepacia complex" (3, 31; Coeyne et al., submitted for publication). Genomovars are phenotypically similar but genotypically distinct groups of strains that show a low level of DNA hybridization. The B. cepacia complex currently includes seven genomovars referred to as B. cepacia genomovar I, B. multivorans (formerly genomovar II), B. cepacia genomovar III, B. stabilis (formerly genomovar IV), and B. vietnamiensis (also known as genomovar V) (3, 31, 32) and two newly identified genomovars, genomovars VI (3) and VII (Coeyne et al., submitted).
Currently it is not known if these Burkholderia species possess different virulence factors or regulate virulence factors differently and subsequently vary in their pathogenicity. Strains of the B. cepacia complex produce a number of potential virulence factors, including siderophores, proteases, lipase, hemolysins, and pili (reviewed in references 10, 12, and 13). Production of extracellular virulence factors does not likely correlate with specific genomovars, since the majority of B. cepacia complex isolates produce these factors. Three markers have been associated with transmissible isolates, including cable pili (28), which have been shown to mediate adherence to respiratory mucins (21); an open reading frame of unknown function with homology to transcriptional regulators, termed the B. cepacia epidemic strain marker (19); and a hybrid of insertion sequences IS402 and IS1356 (30). These three markers have been predominantly found in isolates of B. cepacia genomovar III (2).
Quorum sensing is a signaling mechanism used by bacteria for the coordinate regulation of genes (5, 9, 22, 34). Quorum sensing involves the production of autoinducer signaling molecules, which are normally N-acyl homoserine lactones (AHLs) in gram-negative bacteria, and a transcriptional regulator. Quorum sensing regulates virulence factors, motility, biofilm formation, plasmid transfer, and antibiotic resistance (5, 34).
We have previously described the B. cepacia CepIR quorum-sensing system that was identified in B. cepacia genomovar III strain K56-2 (16). The autoinducer synthase gene, cepI, directs the synthesis of N-octanoyl-L-homoserine lactone (OHL) and N-hexanoyl-L-homoserine lactone (HHL) (16, 17). The transcriptional regulator, CepR, has been shown to negatively regulate biosynthesis of the siderophore ornibactin and positively regulate protease, OHL, and HHL production (16, 17). A second autoinducer synthetase gene, bviI, was identified in B. vietnamiensis DBO1 using random TnMod mutagenesis (6). Quorum-sensing genes have also recently been described in another strain of B. vietnamiensis (B. Conway and E. P. Greenberg, Abstr. 5th Annu. Int. Burkholderia cepacia Working Group Meet., 2000, p. 17, http://www.go.to/cepacia). The objectives of the present study were to determine if the cepIR and bviIR genes were present in other genomovars of the B. cepacia complex and to determine the autoinducer profiles of representative strains in the B. cepacia complex.
The distribution of cepIR and bviIR was
determined in representative strains of the B. cepacia
complex by PCR (Table 1; Fig. 1). The oligonucleotide primers and PCR
conditions used are listed in Table 2.
Genomic DNA was isolated from cultures grown in Luria-Bertani (LB)
broth (Life Technologies, Burlington, Ontario, Canada) as described by
Ausubel et al. (1). Taq polymerase and
oligonucleotide primers were purchased from Life Technologies. PCRs
were carried out in 50-µl volumes with the following amounts of
reagents: 3.2 pmol of primer, 250 ng of DNA, 2.5 U of Platinum Taq
Polymerase, a 0.2 mM concentration of each deoxynucleotide triphosphate
(Amerisham Pharmacia Biotech, Inc., Baie d'urfé, Quebec,
Canada), 3 mM MgCl2, 5 µl of 10× buffer, and 10 µl of Q solution (Qiagen, Mississauga, Ontario, Canada). PCR
products were separated on 0.8% agarose gels in Tris-acetate
buffer. The plasmid pSLA3.2 (16) containing the
cepIR genes was used as a positive control template for
cepI and cepR amplification. The plasmids
p824-E-3, which contains bviI, and p823-E-9, which contains
bviR, were used as positive controls for amplification of
bviI and bviR, respectively. The plasmid pUCP28T
(23) was used a negative control for all PCRs.
|
|
|
Two primer combinations were used to amplify cepR. An 866-bp amplicon containing the complete open reading frame of cepR was amplified using primer set one, CEPR1 and CEPR2, and a 494-bp product containing the N-terminal 163 of 239 amino acids of CepR was amplified with primer set two, CEPR1 and CEPR3. With the exception of strains CEP509 (genomovar I) and C5393 (genomovar III), primer set one amplified cepR in the genomovar I, B. multivorans, genomovar III, B. stabilis, and B. vietnamiensis strains examined (data not shown). cepR was not amplified from strains of either genomovar VI or VII using these primers (data not shown). The primers CEPR1 and CEPR3 amplified an approximately 500-bp product in all strains with the exception of the three genomovar VII strains (Fig. 1A; Table 1). CEPR1 in combination with CEPR4, which amplifies a 575-bp product, also resulted in a negative PCR with the three genomovar VII strains (data not shown).
A 598-bp fragment containing the N-terminal 173 of 202 amino acids of CepI was amplified with the primers CEPI1 and CEPI2 in strains of genomovars I and III, B. stabilis, and B. vietnamiensis but not in B. multivorans or genomovars VI and VII (Fig. 1B). CEPI1 and CEPI3, which amplify a 278-bp product containing the first 93 amino acids of CepI, amplified this product from the same strains (data not shown).
Amplicons of cepI and cepR from one strain from
each genomovar were cloned into the Topo vector pCR 2.1 (Invitrogen,
Carlsbad, Calif.), and the nucleotide sequences were determined with
the ABI PRISM DyeDeoxy Termination Cycle Sequencing System using
AmpliTaq DNA polymerase (Perkin-Elmer Corp.) and the M13 universal
primers and primers internal to cepIR. Reactions were
performed with the ABI1371A DNA sequencer at the University Core DNA
Services (University of Calgary). Sequence alignments were performed
using DNAMAN Sequence Analysis Software (Lynnon Biosoft, Vandreuil,
Quebec, Canada). The 866-bp cepR PCR product was sequenced,
with the exception of genomovar VI LO6. In this instance the 494-bp
amplicon containing only the first 163 amino acids of the predicted
cepR open reading frame was cloned and sequenced. The
predicted amino acid sequences were compared to those of genomovar III,
strain K56-2 CepI and CepR (Table 3). The
percent identity for CepR ranged from 99% in B. vietnamiensis PC259 to 92% in genomovar VI strain LO6. The percent identity for CepI ranged from 96% in B. vietnamiensis strain PC259 to 90% in B. stabilis
strain LMG14291. These results indicate that cepI and
cepR are highly conserved among the strains examined in most
of the genomovars in the B. cepacia complex.
|
bviI was identified in B. vietnamiensis
strain DBO1 as DBO6R using a random plasposon mutagenesis strategy,
as previously described (6). TnMod-KmO
was introduced from Escherichia coli DH5
into DBO1 by
triparental mating with E. coli HB101 (pRK2013) (7). The DNA fragment containing the plasposon's site of
insertion was cloned by performing a total genomic DNA digestion with
PstI (Life Technologies) Bethesda, Md. (a restriction enzyme
that does not cut within the plasposon), purifying the digested
products with Gene-Clean (Bio 101, Santa Clara, Calif). ligating with
T4 DNA ligase (Life Technologies), electroporating into E. coli DH5
, and selecting on LB medium containing 50 µg of
kanamycin per ml. The DNA sequence flanking the plasposon's site of
insertion was determined using the primers JD45
(5'-ACGCTCAGTGGAACG-3') and JD48
(5'-TTCCCGTTGAATATGGC-3') and an ABI 377 DNA sequencer. The TnMod-KmO plasposon was inserted 301 bp from the start of
the bviI open reading frame. The original cloned DNA
fragment containing the rescued plasposon did not contain the complete
sequence of the cognate response regulator bviR; therefore,
the genomic DNA from B. cepacia complex strain DBO6R was
digested with BamHI in order to isolate a larger DNA
fragment flanking TnMod-KmO. This fragment was similarly
cloned as described above. The DNA sequence of bviR was
obtained using a combination of primer walking and from
EcoRI subclones constructed in the nested deletion vector p824 (J. J. Dennis, and G. L. Zylstra, submitted for publication).
bviI encodes a 219-amino-acid protein with 36% identity to
CepI over the first 204 amino acids (Fig.
2). The bviI open reading frame encodes a product that is is 17 amino acids longer than CepI. The
bviR open reading frame encodes a protein of 237 amino acids
that is 36% identical to CepR (Fig. 2). The primers BVII1 and BVII2
amplified a 600-bp product internal to bviI only in strains
of B. vietnamiensis (Fig. 1C). The primers BVIR1 and BVIR2 amplified a 471-bp product internal to bviR in all
representative strains from B. vietnamiensis but not in
strains from the other genomovars (Fig. 1D).
|
B. cepacia K56-I2, a cepI mutant, was used as a reporter strain to detect OHL production by each representative strain (16). When OHL is produced it binds CepR and restores protease production to K56-I2. Strains were streaked perpendicularly to the reporter strain grown on D-BHI (Becton Dickinson, Sparks, Md.)-milk agar (27), and protease production by the reporter was measured after incubation for 48 h. All of the strains tested were able to cross-feed the cepI reporter, suggesting that either OHL or other AHL molecules that can activate CepR are produced regardless of whether or not cepI or bviI was detectable by PCR using the indicated primers.
To determine the AHLs produced by strains of the various genomovars, an
Agrobacter tumefaciens reporter previously shown to detect
AHLs with 3-oxo-, 3-hydroxy-, and 3-unsubstituted side chains of all
lengths, with the exception of N-butanoyl-L-HSL, was employed to examine AHL production in one strain of each genomovar. A. tumefaciens A136 does not contain a Ti plasmid coding for
an autoinducer synthetase (36). This strain with plasmids
pCF18, which harbors traR, and pCF372, with a
traI-lacZ reporter, allows the detection of exogenous
autoinducer production (8, 36). In the presence of AHLs,
-galactosidase activity observed from the traI-lacZ
reporter is detected by a blue zone at the location of migration on
thin-layer chromotography (TLC).
AHLs were extracted from 20-ml cultures grown in tryptic soy broth
(Becton Dickinson) from one representative strain of each genomovar.
Supernatants were extracted twice with equal volumes of acidified ethyl
acetate (0.1 ml of glacial acetic acid per liter). Ethyl acetate was
removed by rotary evaporation, and the residue was resuspended in 2 ml
ethyl acetate, dried over N2 gas, and resuspended in 100 µl of acidified ethyl acetate. TLC bioassays were performed as
described elsewhere with modifications (24). Samples were
spotted onto C18 reversed-phase TLC plates (20 by 20 cm;
Whatman) and developed using methanol-water (60:40, vol/vol). The
plates were overlaid with a A. tumefaciens A136 culture
prepared as follows. A 3-ml overnight culture was diluted 1/100 into 30 ml of LB and grown to log phase. Cells were pelleted by centrifugation, resuspended in 20 ml of AT (29)-0.5% glucose medium, and
incubated for 30 min. This culture was added to 150 ml of AT
supplemented with 0.7% agar and
5-bromo-4chloro-3-indolyl-
-D-galactopyranoside (X-Gal)
(60 µg/ml). TLC plates were incubated for 24 h at 30°C. Synthetic N-hexanoyl-HSL, N-octanoyl-HSL
and N-decanoyl-HSL (Fluka) were used as reference standards.
As previously reported (16, 17), B. cepacia
K56-2 produces OHL and HHL. AHLs with Rf values
corresponding to those of synthetic OHL and HHL were detected in
extracts in all of the other strains examined (Fig.
3). In addition to OHL and HHL, B. vietnamensis also produced two other AHLs that may be
N-decanoyl-HSL and N-dodecanoyl-HSL. Production
of these four AHLs by B. vietnamiensis G4 has previously
been reported (Conway and Greenberg, Abstr. 5th Annu. Int.
Burkholderia cepacia Working Group Meet.). Since bviI was only amplified by PCR in B. vietnamensis
it is likely that this gene is responsible for the production of one or
both of these AHLs. The genomovar VII strain also produced another AHL
that migrates between OHL and HHL on the TLC plate (Fig. 3).
|
These studies suggest that the cepIR genes are widely distributed in all genomovars of the B. cepacia complex and that B. vietnamiensis has at least two sets of quorum-sensing genes. In the strains examined, the cepI genes were shown to be highly conserved (>90% identical at the amino acid level) in B. cepacia genomovars I and III, B. stabilis, and B. vietnamiensis. cepR was also highly conserved in strains of genomovar VI and B. multivorans, suggesting that these strains likely contain the cepIR genes but that the cepI genes are too divergent to be amplified by the selected primers. Since genomovar VII strains also produce OHL and HHL, it is likely that they have cepIR homologues but that these genes may not be as closely related to the cepIR homologues in the other genomovars. It is also possible, however, that genomovar VII contains a different AHL synthase gene that also directs the synthesis of OHL and HHL in addition to the unidentified molecule with activity in the A. tumefaciens reporter assay.
The bviIR genes were less related to K56-2 cepIR than any of the other cepIR homologues identified. Interestingly, only B. vietnamiensis contained sequences amplified by the primers designed to bviIR. Since B. vietnamiensis produces at least two AHL molecules in addition to OHL and HHL, it is likely that bviIR are involved in the production of these signals. Further studies are needed to determine the role of the cepIR and bviIR genes in virulence in the various species of the B. cepacia complex.
Nucleotide sequence accession numbers. The nucleotide sequences of the cepIR and bviIR genes have been deposited in the GenBank and assigned the following accession numbers: AF296284, AF333002, AF333003, AF333004, AF333005, AF333006, AF333007, AF333008, and AF337814.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by a grant from the Canadian Cystic Fibrosis Foundation. S.L. is the recipient of a studentship award from the Alberta Heritage Foundation for Medical Research.
We thank E. Mahenthiralingam for many of the Burkholderia strains used in this study.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Center, 3330 Hospital Dr., N. W., Calgary, Alberta, Canada T2N 4N1. Phone: (403) 220-6037. Fax: (403) 270-2772. E-mail: psokol{at}ucalgary.ca.
Present address: Department of Microbiology and Immunology,
University of British Columbia, Vancouver, British Columbia, Canada.
Editor: J. D. Clements
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1989. Current protocols in molecular biology, vol. 1. John Wiley & Sons, Inc., New York, N.Y. |
| 2. |
Clode, F. E.,
M. E. Kaufmann,
H. Malnick, and T. L. Pitt.
2000.
Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom.
J. Clin. Microbiol.
38:1763-1766 |
| 3. | Coenye, T., J. J. LiPuma, D. Henry, B. Hoste, K. Vandemeulebrouke, M. Gillis, D. P. Speert, and P. Vandamme. 2001. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int. J. Syst. Evol. Microbiol. 51:271-279[Abstract]. |
| 4. |
Corey, M., and V. Farewell.
1996.
Determinants of mortality from cystic fibrosis in Canada, 1970-1989.
Am. J. Epidemiol.
143:1007-1017 |
| 5. |
de Kievit, T. R., and B. H. Iglewski.
2000.
Bacterial quorum sensing in pathogenic relationships.
Infect. Immun.
68:4839-4849 |
| 6. |
Dennis, J. J., and G. J. Zylstra.
1998.
Plasposons: modular self-cloning minitransposon derivatives for rapid genetic analysis of gram-negative bacterial genomes.
Appl. Environ. Microbiol.
64:2710-2715 |
| 7. |
Figuski, D. H., and D. R. Helenski.
1979.
Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans.
Proc. Natl. Acad. Sci. USA
76:1648-1652 |
| 8. |
Fuqua, C., and S. C. Winans.
1996.
Conserved cis-acting promoter elements are required for density-dependent transcription of Agrobacterium tumefaciens conjugal transfer genes.
J. Bacteriol.
178:435-440 |
| 9. | Fuqua, C., S. C. Winans, and E. P. Greenberg. 1996. Census and consensus in bacterial ecosystems: the LuxR-LuxI family of quorum-sensing transcriptional regulators. Annu. Rev. Microbiol. 50:727-751[CrossRef][Medline]. |
| 10. |
Gilligan, P. H.
1991.
Microbiology of airway disease in patients with cystic fibrosis.
Clin. Microbiol. Rev.
4:35-51 |
| 11. | Govan, J. R., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19[CrossRef][Medline]. |
| 12. |
Govan, J. R., and V. Deretic.
1996.
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.
Microbiol. Rev.
60:539-574 |
| 13. | Govan, J. R., J. E. Hughes, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407[Abstract]. |
| 14. | Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210[Medline]. |
| 15. |
Johnson, W. M.,
S. D. Tyler, and K. R. Rozee.
1994.
Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping.
J. Clin. Microbiol.
32:924-930 |
| 16. |
Lewenza, S.,
B. Conway,
E. P. Greenberg, and P. A. Sokol.
1999.
Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI.
J. Bacteriol.
181:748-756 |
| 17. |
Lewenza, S., and P. A. Sokol.
2001.
Regulation of ornibactin synthesis and N-acyl-L-homoserine lactone production by CepR in Burkholderia cepacia.
J. Bacteriol.
183:2212-2218 |
| 18. |
Mahenthiralingam, E.,
T. Coenye,
J. W. Chung,
D. P. Speert,
J. R. W. Govan,
P. Taylor, and P. Vandamme.
2000.
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.
J. Clin. Microbiol.
38:910-913 |
| 19. | Mahenthiralingam, E., D. A. Simpson, and D. P. Speert. 1997. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J. Clin. Microbiol. 35:808-816[Abstract]. |
| 20. | Pegues, D. A., L. A. Carson, O. C. Tablan, S. C. FitzSimmons, S. B. Roman, J. M. Miller, and W. R. Jarvis. 1994. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group. J. Pediatr. 124:694-702[CrossRef][Medline]. |
| 21. |
Sajjan, U.,
Y. Wu,
G. Kent, and J. Forstner.
2000.
Preferential adherence of cable-piliated Burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants.
J. Med. Microbiol.
49:875-885 |
| 22. | Salmond, G. P., B. W. Bycroft, G. S. Stewart, and P. Williams. 1995. The bacterial `enigma': cracking the code of cell-cell communication. Mol. Microbiol. 16:615-624[CrossRef][Medline]. |
| 23. | Schweizer, H. P., T. Klassen, and T. Hoang. 1996. Improved methods for gene analysis and expression in Pseudomonas spp., p. 229-237. In T. Nakazawa, K. Furukawa, D. Hass, and S. Silver (ed.), Molecular biology of pseudomonads. ASM Press, Washington, D.C. |
| 24. |
Shaw, P. D.,
G. Ping,
S. L. Daly,
C. Cha,
J. E. Cronan, Jr.,
K. L. Rinehart, and S. K. Farrand.
1997.
Detecting and characterizing N-acyl-homoserine lactone signal molecules by thin-layer chromatography.
Proc. Natl. Acad. Sci. USA
94:6036-6041 |
| 25. |
Simpson, I. N.,
J. Finlay,
D. J. Winstanley,
N. Dewhurst,
J. W. Nelson,
S. L. Butler, and J. R. Govan.
1994.
Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.
J. Antimicrob. Chemother.
34:353-361 |
| 26. |
Smith, D. L.,
L. B. Gumery,
E. G. Smith,
D. E. Stableforth,
M. E. Kaufmann, and T. L. Pitt.
1993.
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.
J. Clin. Microbiol.
31:3017-3022 |
| 27. |
Sokol, P. A.,
D. E. Ohman, and B. H. Iglewski.
1979.
A more sensitive plate assay for detection of protease production by Pseudomonas aeruginosa.
J. Clin. Microbiol.
9:538-540 |
| 28. | Sun, L., R. Z. Jiang, S. Steinbach, A. Holmes, C. Campanelli, J. Forstner, U. Sajjan, Y. Tan, M. Riley, and R. Goldstein. 1995. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat. Med. 1:661-666[CrossRef][Medline]. |
| 29. |
Tempe, J.,
A. Petit,
M. Holsters,
M. van Montagu, and J. Schell.
1977.
Thermosensitive step associated with transfer of the Ti plasmid during conjugation: possible relation to transformation in crown gall.
Proc. Natl. Acad. Sci. USA
74:2848-2849 |
| 30. | Tyler, S. D., K. R. Rozee, and W. M. Johnson. 1996. Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients. J. Clin. Microbiol. 34:1610-1616[Abstract]. |
| 31. | Vandamme, P., B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. Lauwers, M. Gillis, K. Kersters, and J. R. Govan. 1997. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int. J. Syst. Bacteriol. 47:1188-1200[CrossRef][Medline]. |
| 32. |
Vandamme, P.,
E. Mahenthiralingam,
B. Holmes,
T. Coenye,
B. Hoste,
P. De Vos,
D. Henry, and D. P. Speert.
2000.
Identification and population structure of Burkholderia stabilis sp. nov (formerly Burkholderia cepacia genomovar IV).
J. Clin. Microbiol.
38:1042-1047 |
| 33. |
Walsh, T. A., and D. P. Ballou.
1983.
Halogenated protocatechuates as substrates for protocatechuate dioxygenase from Pseudomonas cepacia.
J. Biol. Chem.
258:14413-14421 |
| 34. | Williams, P., M. Camara, A. Hardman, S. Swift, D. Milton, V. J. Hope, K. Winzer, B. Middleton, D. I. Pritchard, and B. W. Bycroft. 2000. Quorum sensing and the population-dependent control of virulence. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355:667-680[CrossRef][Medline]. |
| 35. | Yabuuchi, E., Y. Kosako, H. Oyaizu, I. Yano, H. Hotta, Y. Hashimoto, T. Ezaki, and M. Arakawa. 1992. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol. Immunol. 36:1251-1275[Medline]. |
| 36. |
Zhu, J.,
J. W. Beaber,
M. I. More,
C. Fuqua,
A. Eberhard, and S. C. Winans.
1998.
Analogs of the autoinducer 3-oxooctanoyl-homoserine lactone strongly inhibit activity of the TraR protein of Agrobacterium tumefaciens.
J. Bacteriol.
180:5398-5405 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|